If it has anything to do with embryonic stem research, then he probably will veto. But, companies like CLBE don't work with embryonic stem cells. It seems that any mentioning of stem cell research, people associate that with ONLY embryos. Let's not bunch all stem cell research as the same.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.